DJIA 15,307.17 -80.41 -0.52%
NASDAQ 3,463.30 -38.82 -1.11%
S&P 500 1,655.35 -13.81 -0.83%

52.35 0.64 (1.24%)

REAL-TIME: Last trade at

Extended Hours: $51.98 -$0.37 (-0.71%)
Quote as of (NYSE)


company name or ticker

Recent Quotes

AZN $52.35 1.24%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $51.98
Previous Close $51.71
Daily Range $51.94 - $52.72
52-Week Range $39.72 - $52.72
Market Cap $65.4B
P/E Ratio 10.36
Dividend (Yield) $3.80 (5.4%)
Ex-Dividend Date
Dividend Pay Date
02/13/13
03/18/13
Volume 3,134,952
Average Daily Volume 1,838,771
Current FY EPS $5.30

Sector

Healthcare

Industry

Drugs

AstraZeneca plc (ADR) (AZN) Description

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation. Website: http://www.astrazeneca.com/

News & Commentary Rss Feed

The 5 Highest-Paying Dividend Stocks in Big Pharma

Not all top dividend yields are backed up by strong businesses.

AstraZeneca Reaches New 52-Week High (AZN)

The Top 3 Diseases Caused by Stress

Not all stress is bad; but for those who are overstressed, these three diseases could be the end result.

3 Neil Woodford High-Yield Shares

AstraZeneca, BAE Systems, and SSE are three of the master investor's high-income shares.

Results from Phase III Studies of Naloxegol for Treatment of Opioid-Induced Constipation Presented a

Results from Phase III Studies of Naloxegol for Treatment of Opioid-Induced Constipation Presented a

Results from Phase III Studies of Naloxegol for Treatment of Opioid-Induced Constipation Presented at Digestive Disease Week 2013

AstraZeneca: A Dividend Payer With An Attractive Growth Prospect

Statin Users May Have a Reason to Rejoice After This Data

An American Society of Clinical Oncology abstract demonstrates a potentially positive long-term side effect of statin use.

U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying

1 Giant Leap for MannKind

MannKind shares have jumped over the moon lately. What's behind this giant leap?

See More AZN News...

AZN's Top Competitors

AZN $52.35 (1.24%)
Current stock: AZN
JNJ $88.46 (-0.15%)
Current stock: JNJ
NVS $74.62 (-0.01%)
Current stock: NVS
RHHBY $65.65 (1.45%)
Current stock: RHHBY